- KR₩37bn
- KR₩25bn
- KR₩30bn
- 100
- 84
- 44
- 92
Annual balance sheet for Wonbiogen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,776 | 13,758 | 8,485 | 8,536 | 10,776 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 32.9 | 3,838 | 3,346 | 5,242 | 4,905 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,809 | 22,889 | 18,204 | 21,138 | 21,657 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 11,688 | 17,268 | 17,711 | 16,982 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,809 | 38,043 | 38,933 | 42,903 | 41,269 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.374 | 10,899 | 11,583 | 9,347 | 3,307 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,102 | 11,340 | 12,065 | 10,681 | 4,062 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 6,707 | 26,703 | 26,867 | 32,222 | 37,207 |
| Total Liabilities & Shareholders' Equity | 7,809 | 38,043 | 38,933 | 42,903 | 41,269 |
| Total Common Shares Outstanding |